← Leaderboards
Yajing Wang
Thomas Jefferson University
$4,879,456
Attributed
$5,985,780
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,985,780 · 4
By mechanism
R01$5,985,780 · 4
Top collaborators
- Xin-Liang Ma4 shared
- Jianyi Zhang1 shared
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Jeffrey L Benovic$31,875,251
- Xin-Liang Ma$9,519,870
- Douglas Tilley$10,927,203
- Peisong Ma$1,560,000
- Chad A. Shaw$791,849
Others in their field
Other Emerging Leaders on “Adiponectin”
- Robert Clayton Bauer · Columbia University Health Sciences$3,907,161
- Erin R Hascup · Southern Illinois University Sch Of Med$3,595,630
- Jami L Josefson · Lurie Children'S Hospital Of Chicago$3,127,395
- Jorge Eduardo Chavarro · Harvard School Of Public Health$2,566,945
- Anne Peery · Univ Of North Carolina Chapel Hill$2,214,713
- Song-Yi Park · University Of Hawaii At Manoa$2,186,711
Research focus
AdiponectinDiabeticReceptorSignal TransductionNon-DiabeticDiabetes MellitusMortalityProductionMolecularRegulationMorbidity - Disease RateMyocardial IschemiaHeartMediatingHeart FailureEffective TherapyDiabetic PatientIn VivoExperimental StudyAttenuatedFunctional DisorderOrganCessation Of LifeAffect
Grant awards (13)
Improving Cardiac Microenvironment as a Novel Strategy against Diabetic Ischemic Heart Failure$637,732
R01 · FY2025 · HL · contact PI
Dysregulated Adiponectin Transmembrane Signaling in Diabetic CoronaryVascular Injury and Heart Failure$541,191
R01 · FY2025 · HL · contact PI
Dysregulated Adiponectin Transmembrane Signaling in Diabetic CoronaryVascular Injury and Heart Failure$535,223
R01 · FY2024 · HL · contact PI
Targeting Adiponectin for Cardioprotection in the Ischemic Heart$390,229
R01 · FY2024 · HL
Critical Role of Small Extracellular Vesicles in Diabetic Coronary VascularDysfunction and Diabetic Ischemic Heart Failure efforts$359,006
R01 · FY2024 · HL · contact PI
Dysregulated Adiponectin Transmembrane Signaling in Diabetic CoronaryVascular Injury and Heart Failure$551,800
R01 · FY2023 · HL · contact PI
Targeting Adiponectin for Cardioprotection in the Ischemic Heart$390,229
R01 · FY2023 · HL
Critical Role of Small Extracellular Vesicles in Diabetic Coronary VascularDysfunction and Diabetic Ischemic Heart Failure efforts$366,335
R01 · FY2023 · HL · contact PI
Dysregulated Adiponectin Transmembrane Signaling in Diabetic Coronary Vascular Injury and Heart Failure$624,478
R01 · FY2022 · HL · contact PI
Targeting Adiponectin for Cardioprotection in the Ischemic Heart$396,101
R01 · FY2022 · HL
Critical Role of Small Extracellular Vesicles in Diabetic Coronary VascularDysfunction and Diabetic Ischemic Heart Failure efforts$390,549
R01 · FY2022 · HL · contact PI
Critical Role of Small Extracellular Vesicles in Diabetic Coronary Vascular Dysfunction and Diabetic Ischemic Heart Failure efforts.$404,550
R01 · FY2021 · HL · contact PI
Targeting Adiponectin for Cardioprotection in the Ischemic Heart$398,357
R01 · FY2021 · HL